Highlighting Initiatives & Roadmaps for Alternatives to Animal Models in Drug Development
- Reiterating the 3Rs and the type of new approach methods to empower drug development and reduce attrition to the clinic using more human-relevant models
- Sharing Merck KGaA’s three basket approach embodying the 3Rs and applications across drug development
- Highlighting the need for regulatory clarity, international harmonisation, and investment in safe harbour frameworks to de-risk innovation and accelerate the adoption of non-animal methods across the drug development pipeline